Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

141
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
141
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

928
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
928

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resilient outcomes in people with a history of mental disorder during the COVID-19 pandemic: an international 2-years longitudinal prospective study.

Social psychiatry and psychiatric epidemiology·2025
Same author

(Fear of) SARS-CoV-2 infection and psychological distress: a population-based cohort study in southern Switzerland.

Epidemiology and psychiatric sciences·2024
Same author

Have the COVID-19 outbreak and related restrictions affected the right to mental health of people with severe mental health conditions?

International review of psychiatry (Abingdon, England)·2023
Same author

Remote mental health care interventions during the COVID-19 pandemic: An umbrella review.

Behaviour research and therapy·2022
Same author

Adverse childhood experiences and global mental health: avenues to reduce the burden of child and adolescent mental disorders - CORRIGENDUM.

Epidemiology and psychiatric sciences·2022
Same author

Adverse childhood experiences and global mental health: avenues to reduce the burden of child and adolescent mental disorders.

Epidemiology and psychiatric sciences·2022
Same journal

Social inclusion inequalities between individuals with mental disorders and the general population: a systematic review and meta-analysis.

Epidemiology and psychiatric sciences·2026
Same journal

Intersectional inequalities in childhood maltreatment and adolescent emotional problems in England: a random-coefficient MAIHDA analysis.

Epidemiology and psychiatric sciences·2026
Same journal

Mental healthcare utilization among migrants and Swedish-born adults accounting for probable needs, 2006-2022.

Epidemiology and psychiatric sciences·2026
Same journal

Long-term effectiveness of banning highly hazardous pesticides on suicide mortality: a 12-year quasi-experimental study in South Korea.

Epidemiology and psychiatric sciences·2026
Same journal

The association between chronotype and incident dementia: exploring age, educational-attainment and sex differences.

Epidemiology and psychiatric sciences·2026
Same journal

The evolution of suicide mortality in Europe: decline with persistent disparities in an age-period-cohort analysis.

Epidemiology and psychiatric sciences·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

744

Do antidepressants prolong the QT interval?

M Nosè1, C Barbui1

  • 1Department of Public Health and Community Medicine, Section of Psychiatry, University of Verona, Verona, Italy.

Epidemiology and Psychiatric Sciences
|February 6, 2014
PubMed
Summary
This summary is machine-generated.

Some antidepressants like amitriptyline, citalopram, and escitalopram may slightly prolong the QTc interval. The clinical significance of this finding requires further investigation.

More Related Videos

Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

13.5K
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

953

Related Experiment Videos

Last Updated: May 3, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

744
Electrocardiogram Recordings in Anesthetized Mice using Lead II
04:16

Electrocardiogram Recordings in Anesthetized Mice using Lead II

Published on: June 20, 2020

13.5K
Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

953

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Cardiology

Background:

  • Antidepressants are widely prescribed for various mental health conditions.
  • Concerns exist regarding potential cardiovascular side effects of certain antidepressants.
  • QTc prolongation is a known risk factor for serious cardiac arrhythmias.

Purpose of the Study:

  • To analyze the association between specific antidepressants and QTc prolongation.
  • To evaluate the strengths and weaknesses of a recent cross-sectional study on this topic.
  • To discuss the clinical implications and regulatory perspectives.

Main Methods:

  • Cross-sectional study analysis.
  • Review of regulatory authority warnings.
  • Discussion of research and clinical practice implications.

Main Results:

  • Certain antidepressants (amitriptyline, citalopram, escitalopram) show an association with QTc prolongation.
  • The observed magnitude of QTc prolongation is relatively small.
  • Clinical implications of this association remain uncertain.

Conclusions:

  • The association between these antidepressants and QTc prolongation is noted but appears minor.
  • Further research is needed to clarify the clinical relevance.
  • Practitioners should remain aware of potential cardiac effects when prescribing these medications.